MerLion Pharma (Germany)

438 papers and 16.8k indexed citations i.

About

In recent decades, authors affiliated with MerLion Pharma (Germany) have published 438 papers, which have received a total of 16.8k indexed citations. Scholars at this organization have produced 155 papers in Cellular and Molecular Neuroscience, 128 papers in Neurology and 118 papers in Molecular Biology on the topics of Neuroscience and Neuropharmacology Research (112 papers), Botulinum Toxin and Related Neurological Disorders (109 papers) and Neurological disorders and treatments (54 papers). Their work is cited by papers focused on Cellular and Molecular Neuroscience (6.0k citations), Molecular Biology (4.7k citations) and Neurology (3.7k citations). Authors at MerLion Pharma (Germany) collaborate with scholars in Germany, United States and Poland and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and Angewandte Chemie International Edition. Some of MerLion Pharma (Germany)'s most productive authors include Wojciech Danysz, Chris G. Parsons, Albrecht Stöffler, Hans Jörg Möbius, Andrzej Dekundy, Jürgen Frevert, Steven H. Ferris, Frederick A. Schmitt, Rachelle S. Doody and ‌Barry Reisberg.

In The Last Decade

Fields of papers published by authors at MerLion Pharma (Germany)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with MerLion Pharma (Germany) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with MerLion Pharma (Germany) at the time of their publication.

Countries citing scholars working at MerLion Pharma (Germany)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at MerLion Pharma (Germany). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at MerLion Pharma (Germany) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MerLion Pharma (Germany) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025